what’s hiding behind iga nephropathy? case report
DESCRIPTION
What’s hiding behind IgA nephropathy? Case Report. Bauerova L., Honsova E. Department of Pathology, the The First faculty of Medicine and General Teaching Hospital, Charles University Prague Nephropathology training: Department of Clinical and Transplantant Pathology, IKEM. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: What’s hiding behind IgA nephropathy? Case Report](https://reader036.vdocument.in/reader036/viewer/2022062410/56815a05550346895dc7511e/html5/thumbnails/1.jpg)
What’s hiding behind IgA nephropathy?
Case ReportCase Report
Bauerova L., Honsova E. Department of Pathology, the The First faculty of Medicine and General Teaching Hospital, Charles University PragueNephropathology training: Department of Clinical and Transplantant Pathology, IKEM
![Page 2: What’s hiding behind IgA nephropathy? Case Report](https://reader036.vdocument.in/reader036/viewer/2022062410/56815a05550346895dc7511e/html5/thumbnails/2.jpg)
Clinical history:Clinical history:• 31– year – old woman• Proteinuria, fatigue, edema of the hands• Tinnitus and sudden hearing loss of the left ear• Arterial hypertension• Nephrotic proteinuria (5g/day) and microscopic
hematuria• Serum creatinine level of 73μmol/l (0,79mg/dl)• Audiometry → hearing abnormalities• Immunology was negative (ELISA testing – IgA, IgM, IgG,
C3 and C4 complement, extractable nuclear antigen (ENA), anti- nuclear antibodies (ANA), ds-DNA antibodies, ANCA, rheuma factor).
![Page 3: What’s hiding behind IgA nephropathy? Case Report](https://reader036.vdocument.in/reader036/viewer/2022062410/56815a05550346895dc7511e/html5/thumbnails/3.jpg)
IgA
![Page 4: What’s hiding behind IgA nephropathy? Case Report](https://reader036.vdocument.in/reader036/viewer/2022062410/56815a05550346895dc7511e/html5/thumbnails/4.jpg)
![Page 5: What’s hiding behind IgA nephropathy? Case Report](https://reader036.vdocument.in/reader036/viewer/2022062410/56815a05550346895dc7511e/html5/thumbnails/5.jpg)
![Page 6: What’s hiding behind IgA nephropathy? Case Report](https://reader036.vdocument.in/reader036/viewer/2022062410/56815a05550346895dc7511e/html5/thumbnails/6.jpg)
![Page 7: What’s hiding behind IgA nephropathy? Case Report](https://reader036.vdocument.in/reader036/viewer/2022062410/56815a05550346895dc7511e/html5/thumbnails/7.jpg)
Diagnosis:Diagnosis:
IgA nephropathy + suspicious Fabry´s disease↓
Genetic testing was recommended↓
(Low -galactosidase A activity in plasma and leucocytes)
+ Heterozygous mutation of α-Gal A gene
![Page 8: What’s hiding behind IgA nephropathy? Case Report](https://reader036.vdocument.in/reader036/viewer/2022062410/56815a05550346895dc7511e/html5/thumbnails/8.jpg)
IgG-IgA1, IgA1-IgA1 complexes
Complement components
Aberrantly glycosylated IgA1 Aberrantly glycosylated IgA1
Production of antiglycan antibodies
• Proliferation of mesangial cells • Expansion of ECM• Cytokines and growth factors production• Local complement activation
Podocytes and tubular cells
damage
FibronectinFibronectinTType IV ype IV collagencollagen
IgA nephropathyIgA nephropathy
![Page 9: What’s hiding behind IgA nephropathy? Case Report](https://reader036.vdocument.in/reader036/viewer/2022062410/56815a05550346895dc7511e/html5/thumbnails/9.jpg)
Fabry´s diseaseFabry´s disease
• X-linked recessive lysosomal storage disorder• Deficient activity of α-galactosidase A• Clinical manifestations are variable• Skin lesions, corneal dystrophy, paresthesias
and proteinuria• During adulthood: heart disease, premature
cerebrovascular accidents, and progressive renal disease
![Page 10: What’s hiding behind IgA nephropathy? Case Report](https://reader036.vdocument.in/reader036/viewer/2022062410/56815a05550346895dc7511e/html5/thumbnails/10.jpg)
Fabry´s diseaseFabry´s disease
• The link between the metabolic abnormality in Fabry´s disease and kidney tissue injury is still unclear
• In females, there are highly variable levels of enzyme activity and broader range of clinical symptoms
• Most females are affected; in various studies, 12% of Fabry´s patients on dialysis are women
![Page 11: What’s hiding behind IgA nephropathy? Case Report](https://reader036.vdocument.in/reader036/viewer/2022062410/56815a05550346895dc7511e/html5/thumbnails/11.jpg)
In a kidney biopsy sampleIn a kidney biopsy sample• Swollen, finely vacuolated podocytes in LM• Dark blue bodies in semi-thin sections embedded in
epoxy resin• Osmiophilic, lamellar bodies mainly in podocytes
(myelin figures, “zebra” bodies) in ELMI• All renal cells can be affected• Difficulties in cases with more advanced stages of FD
![Page 12: What’s hiding behind IgA nephropathy? Case Report](https://reader036.vdocument.in/reader036/viewer/2022062410/56815a05550346895dc7511e/html5/thumbnails/12.jpg)
A cA case for second opinionase for second opinion
![Page 13: What’s hiding behind IgA nephropathy? Case Report](https://reader036.vdocument.in/reader036/viewer/2022062410/56815a05550346895dc7511e/html5/thumbnails/13.jpg)
Differential diagnosisDifferential diagnosis
• Myelin-like inclusions are not entirely specific for Fabry´s disease
• Long-term treatment with cationic amphiphilic drugs (chloroquine and amiodarone)
• Chloroquine-induced lipidosis in the kidney is not so rare
• Specific curvilinear inclusions curvilinear inclusions in podocytes are not present in FD (Prof. Ferluga in his lecture, 23rd ECP, Helsinki 2011)
Dusan Ferluga: Electron microscopy of Fabry nephropathy and drug-induced phospholipidosis. 23rd ECP, Helsinki 2011
![Page 14: What’s hiding behind IgA nephropathy? Case Report](https://reader036.vdocument.in/reader036/viewer/2022062410/56815a05550346895dc7511e/html5/thumbnails/14.jpg)
The coexistence of IgA nephropathy and The coexistence of IgA nephropathy and Fabry´s disease:Fabry´s disease:
• The coexistence of FD and immune disorders such as SLE, rheumatoid arthritis and pauci-immune and immune complex-mediated necrotizing crescentic glomerulonephritis has been described in the literature
• The combination of FD and IgAN is rare
![Page 15: What’s hiding behind IgA nephropathy? Case Report](https://reader036.vdocument.in/reader036/viewer/2022062410/56815a05550346895dc7511e/html5/thumbnails/15.jpg)
Patient´s follow up:Patient´s follow up:
• Human α-galactosidase A replacement therapy• Antihypertensive drugs with diuretics• Cardiac function and blood pressure in the normal
range• S-Cr:S-Cr: 65 μmol/l (0.71 mg/dl)• Proteinuria decreased (1g/day)• Peripheral edema disappeared• SStill suffering fromtill suffering from: fatigue, paresthesia, tinnitus,
and hearing loss
![Page 16: What’s hiding behind IgA nephropathy? Case Report](https://reader036.vdocument.in/reader036/viewer/2022062410/56815a05550346895dc7511e/html5/thumbnails/16.jpg)
Thank YouThank You